Pharmafile Logo
Pharmafocus logo
Advanced Search

Takeda oncology

Showing 3 posts of 3 posts found.

Pharmaceutical companies and patient advocacy groups: Natural allies in the support of patients

May 25, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Takeda oncology, patient advocacy

As published in the special Market Access section of the latest issue of Pharmafocus, Liz Lewis, Chief Counsel & Compliance …

Feature

Takeda in myeloma research drive

January 14, 2016
Medical Communications, Research and Development Ninlaro, Phase II, Takeda, Takeda oncology, eric low, ixazomib, multiple myeloma, myeloma

Takeda is funding the research charity Myeloma UK to run a Phase II study of its multiple myeloma treatment Ninlaro, …

News

Challenges in oncology R&D

November 18, 2015
Manufacturing and Production, Research and Development Dixie-Lee Esseltine, Takeda, Takeda oncology, Velcade, multiple myeloma, oncology

Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …

Feature
The Gateway to Local Adoption Series

Latest content

Product value to pathway impact: What the CVD Modern Service Framework means for pharma

August 9, 2026

Functional lung imaging offers new possibilities for respiratory care

August 9, 2026

Five Facts about cardiovascular disease

August 9, 2026

Data integrity: the keystone for AI adoption, patient safety and organisational reputation

August 9, 2026

Artificial hearts: a century of innovation

August 9, 2026